Dynavax Technologies Corp (DVAX)

foolphighter (< 20) Submitted: 1/12/07 2:11 AM : Start Price: $6.02 DVAX Score: -47.90

Small biotech has recently released promising late stage trial results for its HEPLSAV hepatitus B vaccine drug, as well as encouraging earlier stage results for its TLR9 agonist in cancer indications. The stock took a large hit Jan. 8th when its TO...

Report this Post Replies: 0 | Reply | Permalink

halmcneely (26.79) Submitted: 11/24/06 5:17 PM : Start Price: $7.70 DVAX Score: -52.14

Stong findings for a much-needed vaccine; results exceed early prognosis. Large populations with Rag Weed Allergy get sustained releif.

Report this Post Replies: 0 | Reply | Permalink

napainvestor (< 20) Submitted: 10/05/06 1:34 PM : Start Price: $6.18 DVAX Score: -51.67

I think that this company is a great 'take-over' candidate.

Report this Post Replies: 0 | Reply | Permalink

sweetwilliam3 (< 20) Submitted: 3/02/07 4:36 PM : Start Price: $4.62 DVAX Score: -45.14

Interesting small biostock. I like the TLR technology approach in terms on inate immune response, looks promising. Recent small setback w/ TOLAMBA isn't really that bad. Hepislav looks very promising. Could be a buy out target for big pharma (the...

Report this Post Replies: 0 | Reply | Permalink

uberpaige (< 20) Submitted: 2/26/07 2:12 PM : Start Price: $5.20 DVAX Score: -44.22

another hope for quick accuracy points.

Report this Post Replies: 0 | Reply | Permalink

tekrider (< 20) Submitted: 12/27/06 11:22 AM : Start Price: $8.98 DVAX Score: -52.76

this company has the best TLR-9 technology and excellent recent clinical trial results on both its allergy program and hepatitis B vaccine program, both of which address large markets.

Report this Post Replies: 0 | Reply | Permalink

southernair (41.84) Submitted: 12/19/06 3:50 PM : Start Price: $9.00 DVAX Score: -53.13

This Co. has a cure for hayfever. There's a very large demand for such a product. Buckle up your seat belts for a nice ride up.

Report this Post Replies: 0 | Reply | Permalink

biodetector (29.42) Submitted: 12/15/06 12:09 PM : Start Price: $9.37 DVAX Score: -53.09

I was evaluating their research data regarding influenza vaccines and missed the doubling in stock price, but this may just be the start. Their patented methods widen the range of protection from immunizations. This could be HUGE if it means protec...

Report this Post Replies: 0 | Reply | Permalink

billblattner (24.67) Submitted: 12/12/06 10:49 AM : Start Price: $9.90 DVAX Score: -54.17

This sock is moving up, and its on news that has nothing to do with the alergy break thu, that will propel this company to the outer limits. All of my family has an alergy problem and are waiting for this pill or shot.

Report this Post Replies: 0 | Reply | Permalink

hawkider (70.22) Submitted: 12/07/06 4:04 PM : Start Price: $9.52 DVAX Score: 54.04

House of cards

Report this Post Replies: 0 | Reply | Permalink